Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2525

1.

Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib.

Yang Q, Zhao Y, Li C, Luo Y, Hao W, Zhang W.

Medicine (Baltimore). 2018 Jun;97(25):e11149. doi: 10.1097/MD.0000000000011149.

2.

The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.

Toplak N, Blazina Š, Avčin T.

Drug Des Devel Ther. 2018 Jun 8;12:1633-1643. doi: 10.2147/DDDT.S114532. eCollection 2018. Review.

3.

Haploinsufficiency of A20 and other paediatric inflammatory disorders with mucosal involvement.

Aeschlimann FA, Laxer RM.

Curr Opin Rheumatol. 2018 Jun 16. doi: 10.1097/BOR.0000000000000532. [Epub ahead of print]

PMID:
29916847
4.

Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.

Li H, Abramova I, Chesoni S, Yao Q.

Clin Rheumatol. 2018 Jun 17. doi: 10.1007/s10067-018-4178-z. [Epub ahead of print]

PMID:
29909561
5.

Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.

Emmi G, Urban ML, Imazio M, Gattorno M, Maestroni S, Lopalco G, Cantarini L, Prisco D, Brucato A.

Curr Cardiol Rep. 2018 Jun 14;20(8):61. doi: 10.1007/s11886-018-1007-6. Review.

PMID:
29904899
6.

SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response.

Crowl JT, Stetson DB.

Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 201802114. doi: 10.1073/pnas.1802114115. [Epub ahead of print]

7.

Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics.

Bridgewood C, Watad A, Cuthbert RJ, McGonagle D.

Curr Opin Rheumatol. 2018 Jun 9. doi: 10.1097/BOR.0000000000000529. [Epub ahead of print]

PMID:
29889692
8.

JAK inhibitors in autoinflammation.

Hoffman HM, Broderick L.

J Clin Invest. 2018 Jun 11. pii: 121526. doi: 10.1172/JCI121526. [Epub ahead of print]

9.

IL-1β induces expression of costimulatory molecules and cytokines but not immune feedback regulators in dendritic cells.

Michelini S, Sarajlic M, Duschl A, Horejs-Hoeck J.

Hum Immunol. 2018 Jun 7. pii: S0198-8859(18)30175-7. doi: 10.1016/j.humimm.2018.06.002. [Epub ahead of print]

PMID:
29886260
10.

The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.

Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M.

Autoimmun Rev. 2018 Jun 6. pii: S1568-9972(18)30135-6. doi: 10.1016/j.autrev.2018.01.024. [Epub ahead of print] Review.

PMID:
29885546
11.

The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.

Shillitoe B, Bangs C, Guzman D, Gennery AR, Longhurst HJ, Slatter M, Edgar DM, Thomas M, Worth A, Huissoon A, Arkwright PD, Jolles S, Bourne H, Alachkar H, Savic S, Kumararatne DS, Patel S, Baxendale H, Noorani S, Yong PFK, Waruiru C, Pavaladurai V, Kelleher P, Herriot R, Bernatonienne J, Bhole M, Steele C, Hayman G, Richter A, Gompels M, Chopra C, Garcez T, Buckland M.

Clin Exp Immunol. 2018 Jun;192(3):284-291. doi: 10.1111/cei.13125.

PMID:
29878323
12.

Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases.

Davis MDP, van der Hilst JCH.

J Allergy Clin Immunol Pract. 2018 Jun 2. pii: S2213-2198(18)30328-3. doi: 10.1016/j.jaip.2018.05.006. [Epub ahead of print] Review.

PMID:
29871797
13.

Ultrasound targeting of Q-starch/miR-197 complexes for topical treatment of psoriasis.

Lifshiz Zimon R, Lerman G, Elharrar E, Meningher T, Barzilai A, Masalha M, Chintakunta R, Hollander E, Goldbart R, Traitel T, Harats M, Sidi Y, Avni D, Kost J.

J Control Release. 2018 Jun 2;284:103-111. doi: 10.1016/j.jconrel.2018.05.040. [Epub ahead of print]

PMID:
29870766
14.

The binding of TBK1 to STING requires exocytic membrane traffic from the ER.

Ogawa E, Mukai K, Saito K, Arai H, Taguchi T.

Biochem Biophys Res Commun. 2018 Jun 7. pii: S0006-291X(18)31290-7. doi: 10.1016/j.bbrc.2018.05.199. [Epub ahead of print]

PMID:
29870684
15.

Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.

Deuteraiou K, Kitas G, Garyfallos A, Dimitroulas T.

Rheumatol Int. 2018 Jun 4. doi: 10.1007/s00296-018-4074-5. [Epub ahead of print] Review.

PMID:
29869008
16.

Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.

Shim DW, Lee KH.

Front Immunol. 2018 May 18;9:1054. doi: 10.3389/fimmu.2018.01054. eCollection 2018. Review.

17.

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages.

den Hartigh AB, Fink SL.

J Vis Exp. 2018 May 21;(135). doi: 10.3791/57463.

PMID:
29863661
18.

[Autoinflammatory diseases].

Mosdósi B, Tóth B.

Orv Hetil. 2018 Jun;159(23):898-907. doi: 10.1556/650.2018.31068. Hungarian.

PMID:
29860887
19.

[Primary immunodeficiency and autoimmune diseases].

Műzes G, Sipos F.

Orv Hetil. 2018 Jun;159(23):908-918. doi: 10.1556/650.2018.31064. Hungarian.

PMID:
29860882
20.

Tonsillar antimicrobial peptide (AMP) expression profiles of periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) patients.

Gazi U, Agada ME, Ozkayalar H, Dalkan C, Sanlidag B, Safak MA, Mocan G, Bahceciler NO.

Int J Pediatr Otorhinolaryngol. 2018 Jul;110:100-104. doi: 10.1016/j.ijporl.2018.05.005. Epub 2018 May 8.

PMID:
29859567

Supplemental Content

Loading ...
Support Center